TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in child BMIz
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General Self-Efficacy Scale (GSES)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SF-36 Quality of Life Scores (VT, SF, RE, MH)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cho/NAA ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart-to-liver and heart-to-gut ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage increase in PDRig
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Separation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean maximal oxygen uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracranial Pressure (ICP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Cerebral Perfusion Pressure (CPP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Arterial Oxygen Tension to Fraction of Inspired Oxygen Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Increase in Stage 3 and 4 sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Decrease in nocturnal awakenings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Increase in statin prescribing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seropositive rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average GMCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Markers of inflammation (WBC, hs-CRP, ESR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rheological parameters (RBC aggregation, plasma viscosity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived pros of quitting
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Successful placement of epidural injections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Closing time of the fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of nutritional support required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality due to sepsis
Endpoint domain: Mortality/survival
Primary endpoint: Stent fracture rate
Endpoint domain: Adverse events/effects
Primary endpoint: In-stent restenosis
Endpoint domain: Adverse events/effects
Primary endpoint: PBAC score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-36 score improvement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Cmax,ss of linagliptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC tau,ss of linagliptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax,ss of pioglitazone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: needle insertion pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: low frequency/high frequency ratio of HRV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Knee ligament ratings (IKDC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rating of perceived exertion (RPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cervical modifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PHN at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean plasma estrogen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Severity of incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Severity of nocturia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Frequency of leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cost of nutritional support
Endpoint domain: Resource use
Primary endpoint: UAE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: per-person fall rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: swallowing outcome measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Schirmer score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FBUT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: itching symptom improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncertainty management
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Medical communication competence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Internal mammary artery patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: serum retinyl ester response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chylomicron retinyl linoleate response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprandial serum retinol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NLR value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of responders (HAM-D score reduction ≥50%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission (HAM-D score ≤ 7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean HAM-D score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically evaluated vessel clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of hyperpigmentation
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of ET function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global mood state (CGI-S scale)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of life (UW-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Bronchial mucus transport improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean recipient serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Quadriceps femoris volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle power of the more-affected limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: abnormal cold sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: fiberoptic grades of view
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average increase in technetium‐99m methylene diphosphonate uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean AUC0‐24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pseudoarthrosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain reduction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improved sitting and walking tolerances
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hair reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activation of Nrf2 target gene NQO1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of patients with an undetectable viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: VIA/VILI compliance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of cervical intraepithelial neoplasia grade 2 or worse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Wastage rates of lyophilised vaccines
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rates of post-ERCP pancreatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Mean serum amylase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic vascular resistance indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxygen delivery (DO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total PSA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: incidence of cytomegalovirus disease
Endpoint domain: Adverse events/effects
Primary endpoint: time spent out of bed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desirable injection quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rates of treatment responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of patients no longer using antidepressant medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased postoperative bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minimized transfusion requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased systemic inflammatory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: median cord detachment time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease-free interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Index of recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type I fibers increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Capillary/fiber ratio increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cross-section area (CSA) increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ED95 for success (induction and operation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in peak FEV1 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Use of potentially inappropriate medications
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and tolerability of SAR 1118 Ophthalmic Solution
Endpoint domain: Adverse events/effects
Primary endpoint: MBF response to CPT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Identification of deaths
Endpoint domain: Mortality/survival
Primary endpoint: Sensitivity for cardiovascular deaths
Endpoint domain: Mortality/survival
Primary endpoint: Sensitivity for cancer deaths
Endpoint domain: Mortality/survival
Primary endpoint: Plasma antioxidant capacity (ORAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of glandular hypersecretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean length of renal arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean diameter of renal arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: lumbopelvic pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalized calcium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increased phosphate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduced PTH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Objective quantification of wheezes and crackles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Urine cotinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer errors at postintervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Greater self-awareness and behavioral competency at postintervention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: I-FABP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean DDQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Median Danish Prostate Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median detrusor pressure at maximum urinary flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival free of combined events for all-cause death or heart failure hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Baseline PSA value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Surgical Site Infections (SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of days abstinent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percentage of days paid for work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Wrist flexion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal intercourse without a condom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exposure to risky situations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroresponse rate (titers ≥120 mIU/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Distant metastasis at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: General clinical treatment failure at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Energy balance per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effective rates (CR + PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Peripheral blood levels (WBC, Hb, PLT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: re-intervention rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: perianal disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality within 30 days of enrollment
Endpoint domain: Mortality/survival
Primary endpoint: Number of IV antibiotic days per study day
Endpoint domain: Resource use
Primary endpoint: Daily charges among early‐discharge patients
Endpoint domain: Resource use
Primary endpoint: Adiponectinemia levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of participants passing the comprehension test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average number of comprehension questions answered correctly
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Dental mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days of postoperative air leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chest tubes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral mucositis score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reactive oxygen series score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral comfort score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Life-Years (LYs)
Endpoint domain: Mortality/survival
Primary endpoint: average production time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coincidence rate of biopsy pathological results and final diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean FEV(1)AUC(0‐24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oxygenated hemoglobin/myoglobin change (Δ[oxy(Hb + Mb)])
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Deoxygenated hemoglobin/myoglobin change (Δ[deoxy(Hb + Mb)])
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean C avg,ss values of aripiprazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean elimination half-life of aripiprazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of absorption of aripiprazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: major adverse cardiovascular events (MACEs)
Endpoint domain: Mortality/survival
Primary endpoint: estimated MACE-free survival at 12-month follow-up
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of moderate PPH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: risk of surgical failure
Endpoint domain: Mortality/survival
Primary endpoint: incidence of operable cataract
Endpoint domain: Adverse events/effects
Primary endpoint: Ordering of colon cancer screening tests
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion of colon cancer screening tests
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 12-month worry
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction of ccc DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of fluconazole-refractory OPC or EC infections
Endpoint domain: Adverse events/effects
Primary endpoint: Episodes of OPC or EC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Episodes of invasive fungal infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: successful bowel cleansing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-promoting practice scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cortisol reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Immediate pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokine expression decline (TNF alpha, IL‐1, IL‐6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stabilization of LV hypertrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hospital admission rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time in contact with the geriatric department
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total time for procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of PICP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum levels of ICTP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of prosthesis fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of edge coloration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cortisol production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Noradrenaline plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pacing-induced AF duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AF cycle length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Systemic TNF-alpha and C-reactive protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CAC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematologic improvement (HI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes